• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Bilirubin Blood Test Market Analysis

    ID: MRFR/LS/0249-CR
    148 Pages
    Kinjoll Dey
    August 2019

    Bilirubin Blood Test Market Research Report Information by Test Type (Total Serum Bilirubin), Product Type (Consumables and Instruments), Applications (Pediatric/Infants and Adults), End User (Hospitals, Pediatric Clinics) and Region (North America, Europe, Asia Pacific and Rest of the World (RoW)) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Bilirubin Blood Test Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Bilirubin Blood Test Market Industry Landscape

    In the realm of medical technology, a noticeable divide exists between developed and developing countries, with the former enjoying the benefits of advanced devices, while the latter often relies on traditional methods and large-scale equipment. This technological gap is particularly evident in the field of bilirubin blood testing. Developed nations such as the U.S., Japan, and Germany boast access to cutting-edge portable bilirubin blood test devices, facilitating more efficient and streamlined diagnostic processes. In contrast, many developing countries, grappling with slower technological advancements and limited access to such sophisticated devices, continue to employ traditional methods and bulky equipment. This disparity in technological adoption presents a unique market dynamic, with untapped opportunities for growth in developing regions. Countries like China and India, marked by burgeoning populations and a growing need for advanced healthcare solutions, emerge as potential markets for the expansion of the bilirubin blood test market. However, challenges persist, as major manufacturers predominantly based in developed nations tend to distribute their devices globally, including to developing countries. This approach can inadvertently escalate the cost of these advanced products, limiting accessibility for healthcare professionals in regions with constrained resources.

    To address this issue and seize untapped opportunities, manufacturers are encouraged to reevaluate their distribution strategies. Instead of primarily focusing on established markets in developed nations, they can redirect their attention to the unexplored potential in developing countries. By doing so, manufacturers not only contribute to bridging the technological gap but also position themselves to capture a significant share of emerging markets.

    The evolving landscape of global healthcare demands a more inclusive approach, recognizing the diverse needs and resources of both developed and developing regions. Manufacturers should consider adapting their products to cater to the specific requirements of developing countries, keeping in mind factors such as cost-effectiveness, ease of use, and compatibility with existing healthcare infrastructure.

    In addition to expanding market reach, this shift in focus can have positive implications for public health in developing nations. Access to advanced diagnostic tools, such as portable bilirubin blood test devices, can enhance the efficiency and accuracy of medical assessments. This, in turn, contributes to early detection and intervention for conditions like neonatal jaundice, significantly improving health outcomes.

    Collaborative efforts between manufacturers, healthcare professionals, and regulatory bodies can further facilitate the introduction of advanced medical technologies in developing regions. Initiatives aimed at reducing barriers to entry, providing training programs for healthcare personnel, and optimizing supply chains can accelerate the integration of innovative healthcare solutions.

    The global landscape of medical technology is marked by a stark contrast between developed and developing countries. The potential for growth in the bilirubin blood test market lies in addressing this divide by redirecting focus toward untapped opportunities in regions with evolving healthcare needs. Manufacturers have a pivotal role in driving this transformation, not only by expanding market reach but also by contributing to the improvement of healthcare standards in developing nations.

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Get In Touch

    Leave a Comment

    FAQs

    What would be the projected CAGR for the bilirubin blood test market for the forecast period of 2024-2032?

    The projected CAGR for the forecast period would be 6.63%.

    What is the projected market valuation until 2032?

    The bilirubin blood test market valuation would touch USD 2.25 Billion.

    What was the total serum bilirubin market share in 2032?

    The total serum bilirubin market share was 47.37%.

    Discuss the applications involved in the bilirubin blood test market report.

    The applications involve pediatric/infants and adults.

    Mention the end users discussed in the bilirubin blood test market report.

    The report includes hospitals, home healthcare, and pediatric clinics for discussion.

    Market Summary

    As per Market Research Future Analysis, the Bilirubin Blood Test Market was valued at USD 1.17 Billion in 2023 and is projected to grow to USD 2.25 Billion by 2032, with a CAGR of 6.63% from 2024 to 2032. The market is driven by increasing cases of jaundice and gallbladder issues, particularly in infants. The demand for portable testing kits is rising due to technological advancements and growing awareness of health. However, competition from alternative testing methods poses a challenge. Key players are focusing on developing less invasive testing techniques to cater to the pediatric population.

    Key Market Trends & Highlights

    The Bilirubin Blood Test Market is witnessing significant growth driven by technological advancements and increasing health awareness.

    • Market Size in 2023: USD 1.17 Billion
    • Projected Market Size by 2032: USD 2.25 Billion
    • CAGR from 2024 to 2032: 6.63%
    • Largest Regional Market Share in 2014: North America at 39.10%

    Market Size & Forecast

    2023 Market Size USD 1.17 Billion
    2024 Projected Market Size USD 1.26 Billion
    2032 Projected Market Size USD 2.25 Billion
    CAGR (2024-2032) 6.63%

    Major Players

    Key players include Koninklijke Philips N.V., Beckman Coulter, Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Hoffmann-La Roche AG, and Drägerwerk AG & Co. KGaA.

    Market Trends

    The increasing prevalence of liver diseases and the rising awareness regarding early diagnosis are driving the demand for bilirubin blood tests, which are essential for assessing liver function and overall health.

    Centers for Disease Control and Prevention (CDC)

    Bilirubin Blood Test Market Market Drivers

    Market Growth Projections

    The Global Bilirubin Blood Test Market Industry is projected to experience substantial growth over the next decade. With a market value of 1.26 USD Billion in 2024, it is expected to reach 2.73 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 7.27% from 2025 to 2035. Factors contributing to this expansion include rising incidences of liver disorders, technological advancements in diagnostic tools, and increasing awareness of preventive healthcare. The market's evolution is likely to be influenced by demographic shifts, regulatory support, and ongoing innovations in testing methodologies.

    Rising Geriatric Population

    The global increase in the geriatric population significantly impacts the Global Bilirubin Blood Test Market Industry. Older adults are more susceptible to liver diseases and related complications, necessitating regular monitoring of bilirubin levels. As the population aged 65 and above continues to grow, healthcare systems are adapting to meet the needs of this demographic. This trend is particularly pronounced in developed countries, where the aging population is projected to double by 2050. The demand for bilirubin testing is likely to rise in tandem, contributing to the overall growth of the market as healthcare providers prioritize the management of liver health in older patients.

    Rising Incidence of Liver Disorders

    The increasing prevalence of liver disorders, such as hepatitis and cirrhosis, drives the demand for the Global Bilirubin Blood Test Market Industry. According to health statistics, liver diseases affect millions globally, necessitating regular monitoring of bilirubin levels. This trend is particularly evident in regions with high rates of viral hepatitis, where early detection through bilirubin tests can significantly improve patient outcomes. As awareness of liver health grows, healthcare providers are likely to recommend bilirubin testing more frequently, contributing to the market's expansion. The market is projected to reach 1.26 USD Billion in 2024, reflecting this rising demand.

    Regulatory Support for Diagnostic Testing

    Regulatory bodies worldwide are increasingly supporting the development and implementation of diagnostic testing, including bilirubin blood tests, which positively influences the Global Bilirubin Blood Test Market Industry. Initiatives aimed at improving healthcare quality and access to diagnostic services encourage the adoption of bilirubin testing in clinical settings. Governments are investing in healthcare infrastructure and promoting guidelines that recommend routine testing for liver function. This regulatory support not only enhances the credibility of bilirubin tests but also fosters innovation in testing methodologies. As a result, the market is poised for growth, driven by favorable policies and increased funding for diagnostic services.

    Growing Awareness of Preventive Healthcare

    The increasing emphasis on preventive healthcare is a key driver for the Global Bilirubin Blood Test Market Industry. As individuals become more health-conscious, there is a rising demand for routine health screenings, including bilirubin tests. Public health campaigns and educational initiatives promote the importance of early detection of liver-related issues, encouraging individuals to undergo regular testing. This shift towards preventive measures is likely to result in a higher volume of bilirubin tests conducted annually. Consequently, the market is anticipated to expand, with projections indicating a growth to 2.73 USD Billion by 2035, reflecting the changing attitudes towards health management.

    Technological Advancements in Diagnostic Tools

    Technological innovations in diagnostic tools enhance the accuracy and efficiency of bilirubin blood tests, thereby propelling the Global Bilirubin Blood Test Market Industry. Advances in laboratory equipment, such as automated analyzers and point-of-care testing devices, facilitate quicker and more reliable results. These innovations not only improve patient care but also streamline laboratory workflows, making bilirubin testing more accessible. As healthcare facilities adopt these advanced technologies, the market is expected to grow significantly. The projected compound annual growth rate (CAGR) of 7.27% from 2025 to 2035 underscores the potential for continued growth driven by these advancements.

    Market Segment Insights

    Regional Insights

    Key Companies in the Bilirubin Blood Test Market market include

    Industry Developments

    Future Outlook

    Bilirubin Blood Test Market Future Outlook

    The Bilirubin Blood Test Market is projected to grow at a 7.27% CAGR from 2024 to 2035, driven by rising liver disease prevalence, technological advancements, and increasing healthcare expenditure.

    New opportunities lie in:

    • Develop portable bilirubin testing devices for home use to enhance patient convenience.
    • Invest in AI-driven analytics for improved diagnostic accuracy and personalized treatment plans.
    • Expand market presence in emerging economies through strategic partnerships with local healthcare providers.

    By 2035, the Bilirubin Blood Test Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

    Market Segmentation

    Competitive Landscape

    • Koninklijke Philips N.V. (Noord-Holland)
    • Beckman Coulter, Inc. (US)
    • Thermo Fisher Scientific Inc. (US)
    • Randox Laboratories Ltd. (UK)
    • Hoffmann-La Roche AG (Switzerland)
    • Drägerwerk AG & Co. KGaA (Germany)
    • Ginevri (Italy)
    • Advanced Instruments (US)
    • Reichert, Inc. (US)
    • Instrumentation Laboratory (US).
    • AVI Healthcare Pvt. Ltd.

    Report Scope

    eport Attribute/Metric Details
    Market Size 2023 1.17 (USD Billion)
    Market Size 2024 1.26 (USD Billion)
    Market Size 2032 2.25 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.63 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Koninklijke Philips N.V. (Noord-Holland), Beckman Coulter, Inc. (US), Thermo Fisher Scientific Inc. (US), Randox Laboratories Ltd. (UK), Hoffmann-La Roche AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Ginevri (Italy), Advanced Instruments (US), Reichert, Inc. (US), Instrumentation Laboratory (US)., AVI Healthcare Pvt. Ltd.
      Key Market Opportunities   Developing Countries Can Become Potential Market For Advanced Bilirubin Blood Test Devices
      Key Market Drivers ·  High Prevalence Of Neonatal Jaundice In Infants ·  Increasing Demand For Portable/Hand-Held Diagnostic Devices

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What would be the projected CAGR for the bilirubin blood test market for the forecast period of 2024-2032?

    The projected CAGR for the forecast period would be 6.63%.

    What is the projected market valuation until 2032?

    The bilirubin blood test market valuation would touch USD 2.25 Billion.

    What was the total serum bilirubin market share in 2032?

    The total serum bilirubin market share was 47.37%.

    Discuss the applications involved in the bilirubin blood test market report.

    The applications involve pediatric/infants and adults.

    Mention the end users discussed in the bilirubin blood test market report.

    The report includes hospitals, home healthcare, and pediatric clinics for discussion.

    1. Report Prologue
    2. Market Introduction
      1. 2.1
      2. Definition 17
      3. Scope Of Study 18
      4. Research Objective
      5. 18
      6. Assumptions & Limitations 18
        1. Assumptions
        2. Limitations 18
      7. 18
      8. Market Structure 19
        1. By Test Type 20
        2. By Product Type 21
        3. By Application 22
        4. By End User 23
      9. 2.6
      10. Market Segmentation 20
      11. 20
      12. 2.6.1.3
      13. Direct/Conjugated Bilirubin Test 20
      14. 21
      15. 21
      16. Analyzer 21
      17. 22
      18. 2.6.3.3
      19. Adults 23
      20. 2.6.4.4
      21. Home Healthcare 24
    3. Research Methodolgy
      1. Primary Research
      2. 26
      3. Secondary Research 26
    4. Market Dynamics
      1. 4.1
      2. Introduction 27
      3. Drivers 28
        1. High Prevalence Of Neonatal
        2. Increasing Demand For Portable/Hand-Held
      4. Jaundice In Infants 28
      5. Diagnostic Devices 28
      6. Restrains 29
        1. Testing Performed
      7. By Non-Laboratory Personnel 29
      8. Opportunity 30
        1. Developing
      9. Countries Can Become Potential Market For Advanced Bilirubin Blood Test Devices
      10. 30
      11. Challenges 30
        1. Risk Of Errors 30
      12. 5
    5. Bilirubin Blood Test Market, By Test Type
      1. Bilirubin Blood Test Market,
      2. By Test Type 31
      3. Total Serum Bilirubin (TSB) 32
      4. Direct/Conjugated
      5. Bilirubin Test 34
      6. Indirect/Unconjugated Bilirubin Test 36
    6. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin Blood
    7. Test Market, By Product Type 38
      1. Consumables 39
      2. Instruments
        1. Analyzers 43
        2. Bilirubinometer 49
      3. 41
      4. 6.3.2.1
      5. Bench-Top 51
    8. Bilirubin Blood Test Market,
      1. By Application
      2. Bilirubin Blood Test Market, By Application 55
      3. Pediatric/Infants 56
      4. Adults 58
    9. Bilirubin
    10. Blood Test Market, By End User
      1. Bilirubin Blood Test Market, By End
      2. User 60
      3. Hospital 61
      4. Pediatric Clinics 63
      5. Home Healthcare 65
    11. Bilirubin Blood Test Market, By Region
      1. Bilirubin Market By Region 67
      2. Bilirubin Blood Test Market,
      3. By Test Type
    12. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    13. Blood Test Market, By Application
    14. Bilirubin Blood Test Market, By End
      1. User
      2. North America 67
      3. Bilirubin Blood Test Market, By
      4. Test Type
    15. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    16. Blood Test Market, By Application
    17. Bilirubin Blood Test Market, By End
      1. User
    18. US 71
    19. Bilirubin Blood Test Market, By Test Type
    20. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin Blood
    21. Test Market, By Application
    22. Bilirubin Blood Test Market, By End User
    23. Canada 75
    24. Bilirubin Blood Test Market, By Test Type
    25. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin Blood
    26. Test Market, By Application
    27. Bilirubin Blood Test Market, By End User
      1. Europe 78
    28. Bilirubin Blood Test Market, By Test Type
    29. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin Blood Test Market,
      2. By Application
    30. Bilirubin Blood Test Market, By End User
      1. 9.3.1
      2. Germany 81
    31. Bilirubin Blood Test Market, By Test Type
      1. Bilirubin
    32. Blood Test Market, By Product Type
    33. Bilirubin Blood Test Market, By Application
    34. Bilirubin Blood Test Market, By End User
    35. UK 84
    36. Bilirubin Blood Test Market, By Test Type
      1. Bilirubin Blood Test Market,
      2. By Product Type
    37. Bilirubin Blood Test Market, By Application
    38. Bilirubin Blood Test Market, By End User
      1. Bilirubin
    39. France 87
    40. Blood Test Market, By Test Type
    41. Bilirubin Blood Test Market, By Product
      1. Type
    42. Bilirubin Blood Test Market, By Application
      1. Bilirubin
    43. Blood Test Market, By End User
      1. Bilirubin Blood
    44. Italy 90
    45. Test Market, By Test Type
    46. Bilirubin Blood Test Market, By Product Type
    47. Bilirubin Blood Test Market, By Application
      1. Bilirubin Blood Test
    48. Market, By End User
      1. Bilirubin Blood Test Market,
      2. By Test Type
    49. Spain 93
    50. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    51. Blood Test Market, By Application
    52. Bilirubin Blood Test Market, By End
      1. User
      2. Bilirubin Blood Test Market,
      3. By Test Type
    53. Rest Of Europe 96
    54. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    55. Blood Test Market, By Application
    56. Bilirubin Blood Test Market, By End
      1. User
      2. Asia-Pacific 99
    57. Bilirubin Blood Test Market, By Test
      1. Type
    58. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    59. Blood Test Market, By Application
    60. Bilirubin Blood Test Market, By End
      1. User
    61. China 103
    62. Bilirubin Blood Test Market, By Test
      1. Type
    63. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    64. Blood Test Market, By Application
    65. Bilirubin Blood Test Market, By End
      1. User
    66. India 106
    67. Bilirubin Blood Test Market, By Test
      1. Type
    68. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    69. Blood Test Market, By Application
    70. Bilirubin Blood Test Market, By End
      1. User
    71. Japan 110
    72. Bilirubin Blood Test Market, By Test
      1. Type
    73. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    74. Blood Test Market, By Application
    75. Bilirubin Blood Test Market, By End
      1. User
      2. Bilirubin Blood Test Market, By
      3. Test Type
    76. South Korea 113
    77. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    78. Blood Test Market, By Application
    79. Bilirubin Blood Test Market, By End
      1. User
      2. Bilirubin Blood Test Market,
      3. By Test Type
    80. Rest Of ASIA-PACIFIC 117
    81. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    82. Blood Test Market, By Application
    83. Bilirubin Blood Test Market, By End
      1. User
      2. Rest Of The World 120
      3. Bilirubin Blood Test Market,
      4. By Test Type
    84. Bilirubin Blood Test Market, By Product Type
      1. Bilirubin
    85. Blood Test Market, By Application
    86. Bilirubin Blood Test Market, By End
      1. User
    87. Company Landscape
      1. Introduction 124
      2. 11
      3. Company Profiles
      4. Koninklijke Philips N.V. 128
        1. Product/Business Segment Overview 128
        2. Financials 128
        3. Key Developments 129
        4. Company Overview 131
        5. Product/Business Segment Overview 131
        6. Financials 132
        7. Key Developments 133
      5. 11.1.1
      6. Company Overview 128
      7. 11.2
      8. Beckman Coulter, Inc. (Danaher) 131
      9. Thermo Fisher Scientific Inc.
        1. Company Overview 134
        2. Product/Business Segment
        3. Financials 135
        4. Key Developments
      10. 134
      11. Overview 134
      12. 136
      13. Randox Laboratories Ltd. 137
        1. Company Overview
        2. Product/Business Segment Overview 137
        3. Financials
        4. Key Developments 137
      14. 137
      15. 137
      16. F. Hoffmann-La Roche
        1. Company Overview 138
        2. Product/Business
        3. Financials 138
        4. Key Developments
      17. AG 138
      18. Segment Overview 138
      19. 140
      20. Drägerwerk AG & Co. KGaA 141
        1. Overview
        2. Product Portfolio 141
        3. Financials 141
        4. Key Developments 142
      21. 141
      22. Ginevri 143
        1. Product Portfolio 143
        2. Financials
      23. 11.7.1
      24. Overview 143
      25. 143
      26. Advanced Instruments 144
        1. Overview 144
        2. Product Portfolio 144
        3. Financials 144
      27. 11.8.4
      28. Key Developments 144
      29. Reichert, Inc. 145
        1. Overview
        2. Product Portfolio 145
        3. Financials 145
      30. 145
      31. Instrumentation Laboratory 146
        1. Overview 146
        2. Product Portfolio 146
        3. Financials 146
        4. Key Developments 147
    88. List Of Tables
    89. GLOBAL
    90. BILIRUBIN BLOOD TEST MARKET, BY TEST TYPE, 2022–2030 (USD MILLION) 31
    91. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY
      1. REGION, 2022–2030 (USD MILLION) 32
    92. NORTH AMERICA: BILIRUBIN
    93. BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 32
    94. EUROPE: BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 33
    95. ASIA-PACIFIC : BILIRUBIN
    96. BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY COUNTRY, 2022–2030
      1. (USD MILLION) 33
    97. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED
      1. BILIRUBIN TEST, BY REGION, 2022–2030 (USD MILLION) 34
    98. NORTH
    99. AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2022–2030 (USD
      1. MILLION) 34
    100. EUROPE: BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED
      1. BILIRUBIN TEST, BY COUNTRY, 2022–2030 (USD MILLION) 35
      2. TABLE 9
      3. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST,
      4. BY COUNTRY, 2022–2030 (USD MILLION) 35
    101. GLOBAL BILIRUBIN
    102. BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY REGION, 2022–2030
      1. (USD MILLION) 36
    103. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET
      1. FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 36
    104. EUROPE:
    105. BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY COUNTRY,
    106. ASIA-PACIFIC : BILIRUBIN BLOOD
    107. TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY COUNTRY, 2022–2030
      1. (USD MILLION) 37
    108. GLOBAL BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 38
    109. GLOBAL BILIRUBIN BLOOD
    110. TEST MARKET FOR CONSUMABLES, BY REGION, 2022–2030 (USD MILLION) 39
    111. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY,
    112. EUROPE: BILIRUBIN BLOOD TEST
    113. MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2030 (USD MILLION) 40
      1. TABLE
    114. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2030
      1. (USD MILLION) 40
    115. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS,
      1. BY REGION, 2022–2030 (USD MILLION) 41
    116. NORTH AMERICA: BILIRUBIN
    117. BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 41
    118. EUROPE: BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY COUNTRY,
    119. ASIA-PACIFIC : BILIRUBIN BLOOD
    120. TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2030 (USD MILLION) 42
    121. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY REGION, 2022–2030
      1. (USD MILLION) 43
    122. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET
      1. FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 43
    123. EUROPE:
    124. BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 44
    125. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 44
    126. GLOBAL BILIRUBIN
    127. BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY REGION, 2022–2030 (USD MILLION)
      1. 45
    128. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 45
    129. EUROPE: BILIRUBIN
    130. BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 46
    131. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC
      1. ANALYZER, BY COUNTRY, 2022–2030 (USD MILLION) 46
    132. GLOBAL
    133. BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY REGION, 2022–2030
      1. (USD MILLION) 47
    134. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET
      1. FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 47
    135. EUROPE:
    136. BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY COUNTRY, 2022–2030
      1. (USD MILLION) 48
    137. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET
      1. FOR BLOOD GAS ANALYZERS, BY COUNTRY, 2022–2030 (USD MILLION) 48
      2. TABLE
    138. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY REGION, 2022–2030
      1. (USD MILLION) 49
    139. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET
      1. FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 49
    140. EUROPE:
    141. BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY COUNTRY, 2022–2030 (USD
      1. MILLION) 50
    142. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 50
    143. GLOBAL BILIRUBIN
    144. BLOOD TEST MARKET FOR BENCH-TOP, BY REGION, 2022–2030 (USD MILLION) 51
    145. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY,
    146. EUROPE: BILIRUBIN BLOOD TEST
    147. MARKET FOR BENCH-TOP, BY COUNTRY, 2022–2030 (USD MILLION) 52
      1. TABLE
    148. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY COUNTRY, 2022–2030
      1. (USD MILLION) 52
    149. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD,
      1. BY REGION, 2022–2030 (USD MILLION) 53
    150. NORTH AMERICA: BILIRUBIN
    151. BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 53
    152. EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY COUNTRY,
    153. ASIA-PACIFIC : BILIRUBIN BLOOD
    154. TEST MARKET FOR HAND-HELD, BY COUNTRY, 2022–2030 (USD MILLION) 54
    155. GLOBAL BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030 (USD
      1. MILLION) 55
    156. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/
      1. INFANTS, BY REGION, 2022–2030 (USD MILLION) 56
    157. NORTH AMERICA:
    158. BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 56
    159. EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 57
    160. ASIA-PACIFIC :
    161. BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY COUNTRY, 2022–2030
      1. (USD MILLION) 57
    162. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR ADULTS,
      1. BY REGION, 2022–2030 (USD MILLION) 58
    163. NORTH AMERICA: BILIRUBIN
    164. BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 58
    165. EUROPE: BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY COUNTRY, 2022–2030
      1. (USD MILLION) 59
    166. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET
      1. FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 59
    167. GLOBAL
    168. BILIRUBIN BLOOD TEST MARKET, BY END USER, 2022–2030 (USD MILLION) 60
    169. GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY REGION, 2022–2030
      1. (USD MILLION) 61
    170. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET
      1. FOR REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION) 61
    171. EUROPE:
    172. BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 62
    173. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 62
    174. GLOBAL BILIRUBIN
    175. BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY REGION, 2022–2030 (USD MILLION)
      1. 63
    176. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 63
    177. EUROPE: BILIRUBIN
    178. BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 64
    179. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC
      1. CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 64
    180. GLOBAL
    181. BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY REGION, 2022–2030 (USD
      1. MILLION) 65
    182. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 65
    183. EUROPE: BILIRUBIN
    184. BLOOD TEST MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 66
    185. ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE,
      1. BY COUNTRY, 2022–2030 (USD MILLION) 66
    186. GLOBAL BILIRUBIN
    187. BLOOD TEST MARKET, BY REGION, 2022–2030 (USD MILLION) 67
      1. TABLE
    188. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2022–2030 (USD
      1. MILLION) 67
    189. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 68
    190. NORTH AMERICA: BILIRUBIN
    191. BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 68
      1. TABLE
    192. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD
      1. MILLION) 69
    193. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    194. NORTH AMERICA: BILIRUBIN BLOOD
    195. TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 70
      1. TABLE 76
    196. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2022–2030 (USD MILLION)
      1. 70
    197. NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030
      1. (USD MILLION) 71
    198. US: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 71
    199. US: BILIRUBIN BLOOD TEST
    200. MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 72
    201. US:
    202. BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD MILLION) 72
    203. US: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2022–2030
      1. (USD MILLION) 73
    204. US: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION,
    205. US: BILIRUBIN BLOOD TEST MARKET,
      1. BY END USER, 2022–2030 (USD MILLION) 74
    206. US: BILIRUBIN
    207. BLOOD TEST MARKET, BY TEST, 2022–2030 (USD MILLION) 74
      1. TABLE 85
    208. CANADA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
      1. 75
    209. CANADA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030
      1. (USD MILLION) 75
    210. CANADA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS,
    211. CANADA: BILIRUBIN BLOOD TEST
    212. MARKET, BY BILIRUBINOMETER, 2022–2030 (USD MILLION) 76
      1. TABLE 89
    213. CANADA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
      1. 76
    214. CANADA: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2022–2030
      1. (USD MILLION) 77
    215. CANADA: BILIRUBIN BLOOD TEST MARKET, BY TEST,
    216. EUROPE: BILIRUBIN BLOOD TEST
    217. MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 78
    218. EUROPE:
    219. BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 78
    220. EUROPE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030
      1. (USD MILLION) 79
    221. EUROPE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS,
    222. EUROPE: BILIRUBIN BLOOD TEST
    223. MARKET, BY BILIRUBINOMETER, 2022–2030 (USD MILLION) 79
      1. TABLE 97
    224. EUROPE: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
      1. 80
    225. EUROPE: BILIRUBIN BLOOD TEST MARKET, BY END EUROPEER, 2022–2030
      1. (USD MILLION) 80
    226. EUROPE: BILIRUBIN BLOOD TEST MARKET, BY TEST,
    227. GERMANY: BILIRUBIN BLOOD TEST
    228. MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 81
    229. GERMANY:
    230. BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 82
    231. GERMANY: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030
      1. (USD MILLION) 82
    232. GERMANY: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    233. GERMANY: BILIRUBIN BLOOD TEST
    234. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 83
    235. GERMANY:
    236. BILIRUBIN BLOOD TEST MARKET, BY END GERMANY, 2022–2030 (USD MILLION) 83
    237. GERMANY: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030
      1. (USD MILLION) 84
    238. UK: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 84
    239. UK: BILIRUBIN BLOOD
    240. TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 85
      1. TABLE 109
    241. UK: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD MILLION) 85
    242. UK: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2022–2030
      1. (USD MILLION) 85
    243. UK: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION,
    244. UK: BILIRUBIN BLOOD TEST MARKET,
      1. BY TEST, 2022–2030 (USD MILLION) 86
    245. FRANCE: BILIRUBIN
    246. BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 87
      1. TABLE
    247. FRANCE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION)
      1. 87
    248. FRANCE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030
      1. (USD MILLION) 88
    249. FRANCE: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    250. FRANCE: BILIRUBIN BLOOD TEST
    251. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 88
    252. FRANCE:
    253. BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2022–2030 (USD MILLION) 89
    254. FRANCE: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030 (USD MILLION)
      1. 89
    255. ITALY: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030
      1. (USD MILLION) 90
    256. ITALY: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS,
    257. ITALY: BILIRUBIN BLOOD TEST
    258. MARKET, BY ANALYZERS, 2022–2030 (USD MILLION) 91
    259. ITALY:
    260. BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2022–2030 (USD MILLION) 91
    261. ITALY: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030
      1. (USD MILLION) 92
    262. ITALY: BILIRUBIN BLOOD TEST MARKET, BY END
      1. USER, 2022–2030 (USD MILLION) 92
    263. ITALY: BILIRUBIN BLOOD
    264. TEST MARKET, BY TEST, 2022–2030 (USD MILLION) 93
    265. SPAIN:
    266. BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 93
    267. SPAIN: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030
      1. (USD MILLION) 94
    268. SPAIN: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS,
    269. SPAIN: BILIRUBIN BLOOD TEST
    270. MARKET, BY BILIRUBINOMETER, 2022–2030 (USD MILLION) 94
      1. TABLE 131
    271. SPAIN: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
      1. 95
    272. SPAIN: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2022–2030
      1. (USD MILLION) 95
    273. SPAIN: BILIRUBIN BLOOD TEST MARKET, BY TEST,
    274. REST OF EUROPE : BILIRUBIN
    275. BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 97
      1. TABLE
    276. REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030
      1. (USD MILLION) 97
    277. REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET,
      1. BY BILIRUBINOMETER, 2022–2030 (USD MILLION) 97
    278. REST OF
    279. EUROPE : BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
      1. 98
    280. REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY END USER,
    281. REST OF EUROPE : BILIRUBIN
    282. BLOOD TEST MARKET, BY TEST, 2022–2030 (USD MILLION) 99
      1. TABLE 140
    283. ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
      1. 99
    284. ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE,
    285. ASIA-PACIFIC: BILIRUBIN BLOOD
    286. TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 100
      1. TABLE
    287. ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2022–2030
      1. (USD MILLION) 101
    288. ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET,
      1. BY APPLICATION, 2022–2030 (USD MILLION) 101
    289. ASIA-PACIFIC:
    290. BILIRUBIN BLOOD TEST MARKET, BY END ASIA-PACIFICER, 2022–2030 (USD MILLION)
      1. 102
    291. ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030
      1. (USD MILLION) 102
    292. CHINA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 103
    293. CHINA: BILIRUBIN BLOOD
    294. TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 103
      1. TABLE
    295. CHINA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD MILLION)
      1. 104
    296. CHINA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    297. CHINA: BILIRUBIN BLOOD TEST
    298. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 105
    299. CHINA:
    300. BILIRUBIN BLOOD TEST MARKET, BY END CHINAER, 2022–2030 (USD MILLION) 105
    301. CHINA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030 (USD
      1. MILLION) 106
    302. INDIA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 106
    303. INDIA: BILIRUBIN BLOOD
    304. TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 107
      1. TABLE
    305. INDIA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD MILLION)
      1. 107
    306. INDIA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    307. INDIA: BILIRUBIN BLOOD TEST
    308. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 108
    309. INDIA:
    310. BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2022–2030 (USD MILLION) 109
    311. INDIA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030 (USD
      1. MILLION) 109
    312. JAPAN: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 110
    313. JAPAN: BILIRUBIN BLOOD
    314. TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 110
      1. TABLE
    315. JAPAN: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD MILLION)
      1. 111
    316. JAPAN: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    317. JAPAN: BILIRUBIN BLOOD TEST
    318. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 112
    319. JAPAN:
    320. BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2022–2030 (USD MILLION) 112
    321. JAPAN: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030 (USD
      1. MILLION) 113
    322. SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT
      1. TYPE, 2022–2030 (USD MILLION) 113
    323. SOUTH KOREA: BILIRUBIN
    324. BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION) 114
      1. TABLE
    325. SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD
      1. MILLION) 114
    326. SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    327. SOUTH KOREA: BILIRUBIN BLOOD
    328. TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 115
      1. TABLE
    329. SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY END SOUTH KOREAER, 2022–2030
      1. (USD MILLION) 116
    330. SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET,
      1. BY TEST, 2022–2030 (USD MILLION) 116
    331. REST OF ASIA-PACIFIC
    332. : BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 117
    333. REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS,
    334. REST OF ASIA-PACIFIC : BILIRUBIN
    335. BLOOD TEST MARKET, BY ANALYZERS, 2022–2030 (USD MILLION) 118
      1. TABLE
    336. REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2022–2030
      1. (USD MILLION) 118
    337. REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST
    338. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 119
    339. REST
    340. OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY END REST OF ASIA-PACIFIC ER, 2022–2030
      1. (USD MILLION) 119
    341. REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST
    342. MARKET, BY TEST, 2022–2030 (USD MILLION) 120
    343. ROW: BILIRUBIN
    344. BLOOD TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 120
      1. TABLE
    345. ROW: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2022–2030 (USD MILLION)
      1. 121
    346. ROW: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2022–2030
      1. (USD MILLION) 121
    347. ROW: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER,
    348. ROW: BILIRUBIN BLOOD TEST
    349. MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 122
    350. ROW:
    351. BILIRUBIN BLOOD TEST MARKET, BY END USER, 2022–2030 (USD MILLION) 123
    352. ROW: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2022–2030 (USD MILLION)
      1. 123
    353. KEY DEVELOPMENTS OF MAJOR MARKET PLAYERS 125
      1. TABLE
    354. KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENTS 129
    355. BECKMAN
      1. COULTER, INC.: KEY DEVELOPMENTS 133
    356. THERMO FISHER SCIENTIFIC
      1. INC.: KEY DEVELOPMENTS 136
    357. F. HOFFMANN-LA ROCHE AG.: KEY DEVELOPMENTS
      1. 140
    358. DRÄGERWERK AG & CO. KGAA: KEY DEVELOPMENTS 142
    359. ADVANCED INSTRUMENTS: KEY DEVELOPMENTS 144
      1. TABLE 196
      2. INSTRUMENTATION LABORATORY: KEY DEVELOPMENTS 147
    360. List Of Figures
    361. GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY TEST TYPE 2022 (%)
      1. 14
    362. GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY PRODUCT TYPE,
    363. GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY APPLICATIONS,
    364. GLOBAL BILIRUBIN MARKET SHARE, BY REGION 2022 (%)
      1. 16
    365. GLOBAL BILIRUBIN MARKET, BY REGION, 2022-2030 (CAGR%) 16
    366. MARKET STRUCTURE OF GLOBAL BILIRUBIN BLOOD TEST MARKET 19
    367. RESEARCH PROCESS 25
    368. DROC OF GLOBAL BILIRUBIN BLOOD
      1. TEST MARKET 27
    369. GROWTH DRIVERS: IMPACT ANALYSIS 28
      1. FIGURE
    370. RESTRAINTS: IMPACT ANALYSIS 29
    371. BILIRUBIN BLOOD TEST MARKET,
      1. BY TEST TYPE, 2022–2030 (USD MILLION) 31
    372. BILIRUBIN BLOOD
    373. TEST MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 38
      1. FIGURE
    374. BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 55
    375. BILIRUBIN BLOOD TEST MARKET, BY END USER, 2022–2030 (USD
      1. MILLION) 60
    376. MARKET SHARE ANALYSIS BY KEY PLAYERS 2022 (%) 124
    377. MARKET COMPETITIVE ANALYSIS BY KEY PLAYERS 2022 (%) 125
    378. KONINKLIJKE PHILIPS N.V.: RECENT FINANCIALS 128
      1. FIGURE 18
      2. KONINKLIJKE PHILIPS

    Bilirubin Blood Test Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027